Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”

Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”

Abstract Background The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumati...

Full description

Bibliographic Details
Main Authors: Sophie-Charlott Seidenfaden, Julie Linding Kjerulff, Niels Juul, Hans Kirkegaard, Mette Fogh Møller, Anna-Marie Bloch Münster, Morten Thingemann Bøtker
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Subjects:
Traumatic brain injury
Biomarker
S100B
GFAP
Diagnostic accuracy
Prehospital triage
Online Access:https://doi.org/10.1186/s13049-021-00891-5

Internet

https://doi.org/10.1186/s13049-021-00891-5

Similar Items